Infliximab for Steroid-Refractory Immune Checkpoint Inhibitor-Induced Acute Pancreatitis

Acute pancreatitis is an infrequent but clinically significant complication of immune checkpoint inhibitor (ICI) therapy. Guidelines recommend high-dose steroids and withdrawal of ICI in patients with severe ICI-induced pancreatitis. Management of steroid-refractory ICI pancreatitis is unclear. Infl...

Descripción completa

Detalles Bibliográficos
Autores principales: Townsend, Matthew J., Hodi, F. Stephen, Grover, Shilpa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043592/
https://www.ncbi.nlm.nih.gov/pubmed/36998343
http://dx.doi.org/10.14309/crj.0000000000001018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10043592/
https://www.ncbi.nlm.nih.gov/pubmed/36998343
http://dx.doi.org/10.14309/crj.0000000000001018

Ejemplares similares